Fulvestrant plus LHRH analogues in male with synchronous breast and prostate cancer

Ann Oncol. 2017 Aug 1;28(8):2027-2028. doi: 10.1093/annonc/mdx198.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Breast Neoplasms, Male / drug therapy*
  • Breast Neoplasms, Male / pathology
  • Estradiol / administration & dosage
  • Estradiol / analogs & derivatives
  • Fulvestrant
  • Gonadotropin-Releasing Hormone / administration & dosage
  • Gonadotropin-Releasing Hormone / analogs & derivatives
  • Humans
  • Letrozole
  • Male
  • Neoplasms, Multiple Primary / drug therapy*
  • Neoplasms, Multiple Primary / pathology
  • Nitriles / administration & dosage
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / pathology
  • Tamoxifen / administration & dosage
  • Triazoles / administration & dosage

Substances

  • Nitriles
  • Triazoles
  • Tamoxifen
  • Fulvestrant
  • Gonadotropin-Releasing Hormone
  • Estradiol
  • Letrozole